Patent · US Revoked

TYK2 inhibitors and uses thereof

US11174265B2 · kind B2 · utility

0Cited by
12References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2020
Grant dateNov 16, 2021
Priority date
Expiry dateMay 4, 2040

Classification

  • Technology area (CPC —)General

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.